Cardiff Oncology reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Cardiff Oncology using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $-0.17 | $-0.20 | 15.0 % |
| Q2 | 2025-07-29 | $-0.21 | $-0.19 | -10.5 % |
| Q1 | 2025-05-08 | $-0.20 | $-0.20 | 0.00 % |
| Q4 | 2025-02-27 | $-0.21 | $-0.25 | 16.0 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $120.00K | $132.86K | -9.68 % |
| Q2 | 2025-07-29 | $121.00K | $123.75K | -2.22 % |
| Q1 | 2025-05-08 | $109.00K | $75.00K | 45.3 % |
| Q4 | 2025-02-27 | $151.00K | $94.17K | 60.4 % |
Cardiff Oncology (CRDF) is scheduled to report earnings on February 26, 2026. The last reported earnings were for reported on November 6, 2025 for Q3.
The Actual EPS was $-0.17, which beat the estimate of $-0.20.
The Actual Revenue was $120K, which missed the estimate of $132.9K.
Browse earnings estimates, EPS, and revenue on all stocks.